Each Friday, we feature a physician executive or a physician entrepreneur. This week, Dr. Soon-Shiong is our featured physician. Dr. Patrick Soon-Shiong is the Executive Chairman and Chief Executive Officer of Abraxis Health..
Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. The Abraxis portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound (ABRAXANE) which is based on its proprietary tumor targeting system known as the nab™ Technology platform.
He was recently appointed Executive Director of the UCLA Wireless Health Institute, and is Professor of Microbiology, Immunology, and Molecular Genetics Professor of Bioengineering at UCLA.
Dr. Soon-Shiong holds a degree in Medicine from the University of the Witwatersrand, Johannesburg, South Africa, and a Master of Science from the University of British Columbia. He is a fellow of the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada.